Cathie Wood’s ARK Investment buys 255K shares of Cerus today
EDT Cathie Wood’s ARK Investment buys 255K shares of Cerus (CERS) today Published first on TheFly – the ultimate source for ...
Cerus price target lowered to $3 from $6 at Stifel
Stifel analyst Mathew Blackman lowered the firm’s price target on Cerus to $3 from $6 and keeps a Buy rating on the shares ...
bovnews1d
Uncover the Reason: Why Cerus Corp (CERS) Stock Is Trading 40.50% Above Its 52-Week Low?
On Friday, Cerus Corp (CERS) stock saw a modest uptick, ending the day at $1.7 which represents a slight increase of $0.07 or 4.29% from the prior close of $1.63. The stock opened at $1.63 and touched ...
Cerus Corporation Announces Workshop and Abstracts at the 2024 AABB Annual Meeting
Cerus Corporation (Nasdaq: CERS) today announced a selection of abstracts to be presented at the 2024 Association for the Advancement of Blood & Biotherapies (AABB) Annual Meeting, taking place in ...
Cerus Corporation Provides Updates on INTERCEPT Red Blood Cell Programs in the U.S. and Europe
Cerus Corporation (Nasdaq:CERS) today announced updates on the INTERCEPT red blood cell (RBC) programs in the U.S. and in Europe: ...
Stifel Nicolaus Trims Cerus (NASDAQ:CERS) Target Price to $3.00
Cerus (NASDAQ:CERS – Free Report) had its target price trimmed by Stifel Nicolaus from $6.00 to $3.00 in a report issued on Thursday morning, MarketBeat.com reports. The brokerage currently has a buy ...
Cerus (CERS) Gets a Buy from Craig-Hallum
In a report released today, William Bonello from Craig-Hallum maintained a Buy rating on Cerus (CERS – Research Report). The ...
Morningstar6d
Cerus Corporation Provides Updates on INTERCEPT Red Blood Cell Programs in the U.S. and Europe
U.S. – BARDA award and program update In the U.S., Cerus has entered into a new six-year agreement with the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S ...
Cerus Shares Down 7.2% After Failing to Win CE Mark Approval in Europe
Shares of Cerus fell in the after-hours market Wednesday after the company said its CE Mark review in Europe concluded without an approval. The stock declined 7.2% to $1.67, and ended market trading ...
Investing6d
Cerus secures $248 million BARDA contract for RBC system
CONCORD, Calif. - Cerus (NASDAQ:CERS) Corporation (NASDAQ:CERS) has announced a substantial new contract with the Biomedical Advanced Research and Development Authority (BARDA) valued at up to $ ...
Business Wire6d
Cerus Corporation Provides Updates on INTERCEPT Red Blood Cell Programs in the U.S. and Europe
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq:CERS) today announced updates on the INTERCEPT red blood cell (RBC) programs in the U.S. and in Europe: U.S. – New $248 million BARDA ...
Morningstar4d
Cerus Corporation Announces Workshop and Abstracts at the 2024 AABB Annual Meeting
The following is a select list of Cerus-related presentations and abstracts. All presentation times are listed in Central Daylight Time (CDT). Cerus Corporation is dedicated solely to safeguarding ...